US stock index futures showed mixed movements as major companies reported disappointing earnings, sending some of their stocks tumbling in premarket trading. Notable heavyweights such as Ford Motor Co., Qualcomm Inc., and others faced sell-offs despite beating analyst expectations in certain areas.

Ford Motor Co. Faces Setback in 2025 Guidance

Ford’s stock dropped over 5% in premarket trading after the automaker issued weaker-than-expected guidance for 2025, citing “headwinds related to market factors.” While Ford surpassed Wall Street’s fourth-quarter expectations, the soft outlook for next year sent investors into a cautious mood.

Bristol Myers Squibb Misses Full-Year Revenue Estimates

Shares of Bristol Myers Squibb saw a nearly 6% decline after the biopharmaceutical company provided a full-year outlook that fell short of Wall Street’s expectations. The company projected revenue of about $45.5 billion for 2025, while analysts were looking for $47.36 billion. Despite this, the company continues to show strong growth in other segments.

Qualcomm Inc. Declines Despite Beating Expectations

Qualcomm Inc. saw its stock dip by 5% in premarket trading, despite reporting better-than-expected quarterly results and positive forward guidance. The semiconductor giant earned $3.41 per share on an adjusted basis and brought in revenue of $11.67 billion, surpassing analysts’ forecasts. While its performance exceeded expectations, investors seemed to be reacting cautiously to the company’s outlook.

Honeywell International Faces Pressure Amid Split Plans

Honeywell International’s stock dropped more than 3% following the announcement that the conglomerate will split into three separate companies. This move came as a response to pressure from activist investor Elliott Management. Along with this restructuring plan, Honeywell also issued a 2025 forecast that fell short of analysts’ projections, with expected adjusted earnings per share of $10.10 to $10.50, compared to the $10.92 per share that analysts were anticipating.

Eli Lilly Sees Modest Gains After Earnings Beat

Eli Lilly’s stock edged up 1% after the pharmaceutical giant reported an earnings beat for its fourth quarter. Although revenue came in slightly below expectations, Eli Lilly’s performance in key areas like its weight loss drug, Zepbound, and diabetes treatment, Mounjaro, helped bolster the company’s stock. The company had already disclosed preliminary results in January, which contributed to its market stability.

Arm Holdings Faces Sluggish Performance Despite Strong Quarter

Arm Holdings saw its stock fall by more than 4% despite beating analyst expectations for its third-quarter performance. The company exceeded revenue and earnings expectations for the quarter, but its revised full-year revenue outlook caused concern among investors. Arm now expects annual revenue between $3.94 billion and $4.04 billion, lower than the previous forecast of $3.80 billion to $4.10 billion.

Yum! Brands Rises on Strong Fourth-Quarter Results

On a brighter note, Yum! Brands saw its stock climb approximately 3% after reporting fourth-quarter earnings that slightly beat analyst estimates. The fast food chain earned $1.61 per share, excluding items, while revenue of $2.36 billion matched expectations. The solid earnings performance helped lift the stock in a mixed market.

As these earnings results ripple through the market, investors are navigating through a landscape of uncertainty and caution. While some companies have exceeded expectations, others are facing challenges that have caused their stocks to slip. Investors will be keeping a close eye on further earnings reports in the coming weeks to gauge the health of the broader market.